Found 25 matching trials
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
PHASE2This study will determine 1) the safety of AC2993 in patients with type I d...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Gut Hormones in Obesity, Nicotine and Alcohol Dependence
EARLY_PHASE1The "Gut Hormones in Addiction" study is a proof-of-concept experimental me...
Location
Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, Hammersmith Hospital
Intravenous Exenatide (Byetta) During Surgery
PHASE1The purpose of this project is to study if intravenous Exenatide is effecti...
Location
University of Pennsylvania
Exenatide for Myocardial Protection During Reperfusion Study
PHASE2This study aims to assess the effect of exenatide on myocardial injury in p...
Location
Foothills Medical Centre
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
PHASE4Both pre- and postconditioning seem to protect cardiomyocytes during reperf...
Location
Heart Center, Rigshospitalet
Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
PHASE3Myocardial infarction (MI) causes loss of myocytes and may lead to loss of ...
Location
VU Medical Center
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
PHASE4The purpose of this investigation is to evaluate whether exenatide, a type ...
Location
Phoenix VA Medical Center
Intravenous Exenatide in Patients With Acute Brain Injury
PHASE4The purpose of this study is to assess the feasibility of exenatide infusio...
Location
University of North Carolina; UNC Medical Center
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
PHASE4The purpose of this study is to determine the efficacy of intravenous Exena...
Location
Mid America Heart Institute Saint Luke's Health System
Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
PHASE2The purpose of this study is to determine whether exenatide is effective to...
Location
Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen